Aaron Goldenberg, PhD, MA, MPH is Professor, Research Director, and Vice Chair in the Department of Bioethics & Medical Humanities at ÐÇ¿Õ´«Ã½ School of Medicine.
Dr. Goldenberg received his bachelor's degree from Michigan State University; his MPH from University of Michigan and earned his PhD in Bioethics at ÐÇ¿Õ´«Ã½. Since joining the faculty at ÐÇ¿Õ´«Ã½, Dr. Goldenberg's work focuses on the ethical, legal, and social implications of advances in genomics within clinical and public health settings. His research program has been grounded by a number of major project areas, including: 1) ethical implications of expanding newborn screening programs; 2) storage and use of perinatal and pediatric biological specimens for future research; and 3) the implications of genomics for communities experiencing health disparities. He is currently the Co-PI of a new project assessing the ELSI challenges of networked biorepositories aimed at promoting precision medicine.
In addition to these scholarly initiatives, Dr. Goldenberg is Director for Ethics, Policy and Practice for the National Newborn Screening Clearinghouse, also known as Baby's First Test. He is a member of the Ethics and Legal Workgroup for the Newborn Screening Translational Research Network and the Legal and Legislative Workgroup for the American Public Health Laboratory Association. And, is a member of NIH's IRB for the All of Us Research Program.
Dr. Goldenberg has been an active member of the genetic counseling program. He lectures on research ethics, public health genetics and co-teaches BETH 412 Ethical Issues in Genetics & Genomics. Dr. Goldenberg also sits on a number of the GC student research committees and is a member of the Advisory Board for the Genetic Counseling Program.
Research Information
Research Projects
Dr. Goldenberg’s work focuses on the ethical and social issues surrounding advances in public health genomics, biobanking, health disparities, and the intersection between bioethics and public health ethics. His dissertation focused on the ethical issues surrounding the use of Michigan's residual newborn screening bloodspots for research purposes. Recently, he has been working on a number of projects related to the use of biobanked pediatric samples for genetic research, the use of stored tissues from recently deceased individuals for gene-tissue expression studies (GTEX), and public attitudes towards the use of genetic research to address health disparities.